antipathogenic suture and wound care technologies — Initial data
Late 2026
Animal studies evaluating the Company's antipathogenic suture and wound care technologies are currently scheduled to begin during the third quarter of 2026, with preliminary data expected to be available for potential licensing partners before year-end, subject to study initiation, execution and timing.Source filing